Effect of heat-clearing and detoxifying oral liquid for killing helicobacter

Through the preparation of heat-clearing and detoxifying mixture, traditional Chinese medicine ingredients were used to inhibit Helicobacter pylori, which solved the problem of increased antibiotic resistance and achieved effective inhibition and increased immunity of Helicobacter pylori.

CN119055722APending Publication Date: 2024-12-03SHANDONG NEW TIME PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310648530.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-02
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The rate of resistance to commonly used antibiotics by Helicobacter pylori is rising, and existing treatments lack effective solutions, especially when new, non-drug-resistant antibiotics are difficult to detect.

Method used

Use heat-clearing and detoxifying mixtures, including gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Dermatology, Scutellaria baicalensis, Gentiana, Isatis root, Anaestheticum and other ingredients, and are prepared as oral liquid, syrup or capsules for use in To treat or prevent Helicobacter pylori infection, it is prepared by decoction, concentration, filtration and sterilization, and is treated with ethanol and flavoring agents.

Benefits of technology

The heat-clearing and detoxifying agent significantly inhibits Helicobacter pylori, reduces the use of antibiotics, reduces drug resistance, and has high safety, small side effects, and a variety of pharmacological effects to promote immune enhancement.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004264201520000031
    Figure BDA0004264201520000031
  • Figure BDA0004264201520000041
    Figure BDA0004264201520000041
  • Figure BDA0004264201520000051
    Figure BDA0004264201520000051
Patent Text Reader

Abstract

The invention provides an application of a heat-clearing and detoxifying mixture in preparation of medicines or health-care products for treating or preventing helicobacter pylori infection. The heat-clearing and detoxifying mixture comprises gypsum, honeysuckle, radix scrophulariae, rehmannia, fructus forsythiae, fructus gardeniae, manyflower gueldenstaedtid herb, radix scutellariae, radix gentianae, radix isatidis, rhizoma anemarrhenae, radix ophiopogonis and other pharmaceutically acceptable auxiliary materials. Experiments prove that the heat-clearing and detoxifying mixture has an obvious inhibiting effect on helicobacter pylori and drug-resistant bacteria, and meanwhile, the heat-clearing and detoxifying mixture is high in safety and small in toxic and side effects and has the symptoms of fever, red face, dysphoria, thirst, swollen sore throat and the like caused by exuberance of heat toxins; influenza and upper respiratory tract infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medical technology, and particularly relates to use of a heat-clearing and detoxifying mixture in preparing medicines or health products for treating or preventing Helicobacter pylori infection. Background Art

[0002] Helicobacter pylori (Hp) is a spiral, microaerophilic, Gram-negative bacillus with strong infectivity. Currently, Hp has become one of the most widely infected bacteria in the world, with about half of the world's population infected. Although public health conditions have been greatly improved in recent years, the Hp infection rate in many countries is still very high, especially in developing countries where the infection rate is as high as 70%. The Hp infection rate in my country is about 50%-70%.

[0003] Currently, the eradication treatments for Hp mainly include standard triple therapy and bismuth quadruple therapy. Other eradication regimens include concomitant therapy, sequential therapy, combined therapy, and proecological preparation therapy.

[0004] Standard triple therapy and bismuth quadruple therapy are eradication therapies with antibiotics as the mainstay. Standard triple therapy is: a proton pump inhibitor (PPI) + two antibacterial drugs, with a course of 7 to 14 days; bismuth quadruple therapy is: a PPI + a bismuth + two antibacterial drugs, with a course of 10 or 14 days; commonly used antibiotics include clarithromycin, amoxicillin, metronidazole, tetracycline, furazolidone, levofloxacin and other six types. Several other therapies are also variant therapies with antibiotic therapy as the mainstay.

[0005] With the widespread use of these drugs, the resistance rate of Hp to these antibiotics has also slowly increased. A study in Iran in 2015 showed that the resistance rates of Hp strains in the region to amoxicillin, tetracycline and furazolidone were 16.0%, 12.2% and 21.6% respectively. The resistance rates of amoxicillin and tetracycline showed a rapid growth trend between 1997 and 2013. Faced with the increasing proportion of drug-resistant Hp strains worldwide and the increasing difficulty in discovering new antibiotics that are less resistant, there are currently not many effective methods in clinical practice except for constantly changing antibiotic combinations, increasing antibiotic dosages and prolonging treatment time. Summary of the invention

[0006] The invention provides use of a heat-clearing and detoxifying mixture in preparing medicines or health products for treating or preventing Helicobacter pylori infection.

[0007] Preferably, the drug for treating or preventing Helicobacter pylori infection is a Qingrejie mixture in the form of an oral liquid, syrup, capsule or tablet.

[0008] Preferably, the heat-clearing and detoxifying mixture can be used in combination with other drugs to treat or prevent Helicobacter pylori infection.

[0009] Preferably, the heat-clearing and detoxifying mixture of the present invention comprises the following ingredients: gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Herb, Scutellaria, Gentiana, Isatis, Anemarrhena, Ophiopogon and other pharmaceutically acceptable excipients.

[0010] Preferably, the heat-clearing and detoxifying mixture is composed of the following parts by weight: 670g of gypsum, 134g of honeysuckle, 107g of Scrophularia, 80g of Rehmannia, 67g of Forsythia, 67g of Gardenia, 67g of Sweet Plantain, 67g of Scutellaria, 67g of Gentiana, 67g of Isatis, 54g of Anemarrhena, and 54g of Ophiopogon.

[0011] A method for preparing the above-mentioned Chinese medicinal prescription for treating Helicobacter pylori infection, the method comprising the following steps:

[0012] Step 1: remove impurities from the above-mentioned parts by weight of gypsum, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Herb, Gentiana, Isatis, Anemarrhena, and Ophiopogon, soak in normal temperature water, decoct twice, filter, and concentrate;

[0013] Step 2: Add ethanol to the concentrate of step 1, refrigerate, filter, recover ethanol, add flavoring agent and activated carbon, heat, filter again, add water, filter, fill and sterilize to obtain the heat-clearing and detoxifying oral liquid.

[0014] Preferably, after boiling in step 1, honeysuckle and astragalus are added, and the first decoction is 60 minutes and the second decoction is 40 minutes; the filtrate is concentrated to a relative density of about 1.17 (80°C).

[0015] Preferably, ethanol is added in step 2 to make the alcohol content reach 65%-70%.

[0016] Preferably, the prescription and preparation method of the heat-clearing and detoxifying mixture of the present invention can refer to the Ministry of Health standard WS3-B-1377-93.

[0017] Beneficial effects of the present invention:

[0018] The invention provides a new use of a heat-clearing and detoxifying mixture for resisting Helicobacter pylori, and experiments prove that the mixture has a significant inhibitory effect on Helicobacter pylori, and the application of traditional Chinese medicine can reduce the use of antibiotics, thereby reducing the drug resistance rate of Helicobacter pylori. At the same time, the heat-clearing and detoxifying oral liquid has high safety, small toxic and side effects, and has the effects of dispersing wind and relieving exterior symptoms, dispelling wind and overcoming dampness, unblocking joints, activating blood circulation and promoting qi, dispersing wind and clearing lungs, removing phlegm and relieving cough, strengthening spleen and removing dampness and relieving pain, etc., and can promote the coordinated operation of organs in the body and enhance human immunity. DETAILED DESCRIPTION

[0019] The present invention is further illustrated by the following examples. It should be correctly understood that the examples of the present invention are only used to illustrate the present invention, rather than to limit the present invention. Therefore, simple improvements to the present invention based on the method of the present invention all fall within the scope of protection claimed by the present invention.

[0020] 1. Preparation of Qingrejiedu Mixture

[0021] The Chinese medicine prescription for treating Helicobacter pylori infection is composed of the following raw materials: 670g of gypsum, 134g of honeysuckle, 107g of Scrophularia, 80g of Rehmannia, 67g of Forsythia, 67g of Gardenia, 67g of Sweet Herb, 67g of Scutellaria, 67g of Gentiana, 67g of Isatis, 54g of Anemarrhena, and 54g of Ophiopogon;

[0022] The preparation of the Chinese medicine prescription comprises the following steps:

[0023] Except honeysuckle and scutellaria, the other ten herbs such as gypsum are first soaked in warm water for 1 hour, decocted (after boiling, add honeysuckle and astragalus) twice, the first time for 1 hour, the second time for 40 minutes, filtered, combined the filtrate, concentrated the filtrate to a relative density of about 1.17 (80°C), added ethanol to make the alcohol content reach 65%-70%, refrigerated for 48 hours, filtered, recovered ethanol from the filtrate, added appropriate amount of flavoring agent, added 5g of activated carbon, heated for 30 minutes, filtered, added water to 1000mL, filtered, sealed, sterilized, and the heat-clearing and detoxifying mixture was obtained.

[0024] 2. In vitro antibacterial experiment of Jingfang preparation

[0025] 1. MIC value determination

[0026] Test drug: Qingrejiedu mixture (prepared according to the method of the present invention), and positive control drug is clarithromycin (MCE Company, batch number: 16542).

[0027] Strains: Helicobacter pylori standard strains ATCC43504, ATCC700392, SS1, NCTC26695; Resistant strains: QYZ-001, QYZ-003.

[0028] Methods: After the Qingrejiedu mixture was filtered with a 0.22μm filter membrane, multiple concentration gradients of 400μl / ml, 200μl / ml, 100μl / ml, 50μl / ml, 25μl / ml, 12.5μl / ml and other drugs were prepared by the two-fold dilution method. The antibiotic clarithromycin was used as a positive control and dissolved in DMSO to prepare a stock solution. When used, it was diluted to the corresponding multiple concentration gradients (DMSO content ≤1%). 50μl of the prepared drug solution was drawn into a 96-well plate. At least 3 replicate wells were set for each drug concentration, and negative control wells (containing only drugs and no strains were inoculated), growth control wells (containing no drugs and only strains were inoculated) and clarithromycin positive control wells (containing clarithromycin and inoculated with strains) were set. Take out the strain from the incubator, scrape the bacterial moss with a moistened sterile cotton swab into PBS, adjust the turbidity of the bacterial suspension to 1 McF with BHI containing 20% ​​FBS, dilute 10 times and inoculate in the above-mentioned 96-well plate containing the drug (the final turbidity of the bacterial suspension in the 96-well plate is about 1×10 6 CFU / ml), and immediately place the 96-well plate in an incubator, 37°C, microaerobic conditions, 150rpm shaking culture for 72 hours, and then take out and observe the results. The results are available only when the growth control is button-shaped or obviously turbid. Observe from bottom to top with the naked eye. The drug concentration when the bacterial turbidity is significantly reduced is the MIC. The determination of the MIC value is completed within 3 generations after recovery, and the MIC value determination is repeated 3 times. The inhibition results of Qingrejiedu Mixture on Helicobacter pylori are shown in Table 1.

[0029]

[0030]

[0031] Note: “-” indicates no bacterial growth, and “+~++++” indicates bacterial growth.

[0032] According to the above test results, the inhibitory effects of Qingrejiedu Mixture on Helicobacter pylori from different sources are shown in Table 2.

[0033] Table 2

[0034] Bacteria ATCC43504 ATCC700392 SS1 NCTC26695 QYZ-001 QYZ-003 MIC (μl / ml) 50 25 50 50 25 50

[0035] 2. Determination of MBC value

[0036] Take out the 96-well plate cultured for 72 hours in the microbroth assay, and draw 100 μL of liquid from the 1-fold MIC, 2-fold MIC, and 4-fold MIC drug concentration wells and evenly spread them on the fresh blood plate. After 72 hours of culture, take out the results and observe them. The drug concentration that kills 99.9% of the number of bacteria is the MBC. The results of the inhibition of Qingrejiedu mixture on various Helicobacter pylori are shown in Table 3.

[0037] Table 3

[0038] Bacteria ATCC43504 ATCC700392 SS1 NCTC26695 QYZ-001 QYZ-003 MIC (μl / ml) 50 25 50 50 25 50

[0039] As shown in Table 1-3, Jingfang mixture has good inhibitory activity against multiple sensitive / resistant Helicobacter pylori strains, with MIC values ​​ranging from 25-50μl / mL and MBC values ​​ranging from 25-50μl / ml. This indicates that Qingrejiedu mixture has very effective inhibitory and killing effects on standard strains and resistant strains of Helicobacter pylori in vitro.

[0040] 3. Effect of Qingrejiedu Mixture on the Negative Transformation of Helicobacter pylori

[0041] Experimental methods:

[0042] Preparation of bacterial solution: Helicobacter pylori ATCC43504 strain was inoculated into Brucella agar medium and cultured at 37°C for 3 days in a microaerobic environment. Gram staining was performed for microscopic examination. After urokinase, peroxide and catalase tests were performed to confirm Helicobacter pylori, Brucella broth was used for 3 days to obtain bacterial solution for use; Modeling and experiment: Wistar rats were half male and half female, first gavaged with 5% sodium bicarbonate solution (gavage volume 2mL / rat), and then 15 minutes later, the bacterial solution was gavaged with rats (gavage volume 1.5mL / rat), once a week, for a total of 5 times. After the modeling was completed, tail blood was taken to check for anti-Helicobacter pylori related antibodies, and a positive result was considered a successful modeling. 40 rats were randomly selected and divided into 2 groups, 20 in each group, which were set as the model control group and the experimental group. The rats in the experimental group were gavaged with Qingrejiedu mixture (5mL / kg) once a day for a total of 10 days, and the model control group was gavaged with an equal amount of normal saline. After administration, the rats were fasted for 1 day and then killed. The stomach cavity was cut open and 3 pieces of stomach tissue were taken for gastric mucosal smear, bacterial culture and rapid urokinase test. The positive numbers were counted and the eradication index was defined as the negative of all three indicators. The eradication rate was calculated and the results are recorded in Table 4.

[0043] Table 4

[0044]

[0045] It can be seen from Table 4 above that the composition of the present invention can effectively inhibit Helicobacter pylori. Under the premise of a relatively low dosage, the eradication rate of Helicobacter pylori can eventually reach more than 75%.

Claims

1. A new use of a heat-clearing and detoxifying mixture, characterized in that: The heat-clearing and detoxifying mixture can be used to prepare medicines or health products for treating or preventing Helicobacter pylori infection.

2. The use of the heat-clearing and detoxifying mixture according to claim 1, characterized in that: The heat-clearing and detoxifying mixture comprises the following ingredients: gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Herb, Scutellaria, Gentiana, Isatis, Anemarrhena, Ophiopogon and other pharmaceutically acceptable excipients.

3. The use of the heat-clearing and detoxifying mixture according to claim 1, characterized in that: The heat-clearing and detoxifying mixture is in the form of oral liquid, syrup, capsule or tablet.

4. The use of the heat-clearing and detoxifying mixture according to claim 1, characterized in that: The heat-clearing and detoxifying mixture is an oral liquid.

5. The use of the heat-clearing and detoxifying mixture according to claim 1, characterized in that: The heat-clearing and detoxifying mixture is composed of the following parts by weight: 670g of gypsum, 134g of honeysuckle, 107g of Scrophularia, 80g of Rehmannia, 67g of Forsythia, 67g of Gardenia, 67g of Sweet Peony, 67g of Scutellaria, 67g of Gentiana, 67g of Isatis, 54g of Anemarrhena, and 54g of Ophiopogon.

6. A method for preparing the heat-clearing and detoxifying mixture according to claim 1, characterized in that: The preparation method comprises the following steps: Step 1: remove impurities from 670g of gypsum, 107g of Scrophularia, 80g of Rehmannia, 67g of Forsythia, 67g of Gardenia, 67g of Sweet Herb, 67g of Gentiana, 67g of Isatis, 54g of Anemarrhena, and 54g of Ophiopogon, soak in room temperature water, decoct twice, filter, and concentrate; Step 2: Add ethanol to the concentrate of step 1, refrigerate, filter, recover ethanol, add flavoring agent and activated carbon, heat, filter again, add water, filter, fill and sterilize to obtain the heat-clearing and detoxifying oral liquid.

7. The preparation method according to claim 6, characterized in that: After boiling in step 1, add honeysuckle and astragalus, decoct for 60 minutes for the first time and for 40 minutes for the second time; the filtrate is concentrated to a relative density of about 1.

17.

8. The preparation method according to claim 6, characterized in that: In step 2, ethanol is added to make the alcohol content reach 65%-70%.